本社 14 Giu 2023 製薬、医療技術事業会社の欧州本部 欧州市場への参入を目指す日本のバイオ医薬品企業にとって、スイスは、欧州本部、また欧州・中東・アフリカ事業の地域統括拠点として最適な場所です。地理的なメリット、ビジネスのしやすさ、多様な人材の集積地であることなどが魅力となり、メルクセローノ、武田薬品工業、バイオジェン、ジョンソン・エンド・ジ...
Headquarters 15 Giu 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
News 20 Gen 2021 B. Braun manufacturing COVID-19 vaccination sets Together with two governmental departments in Switzerland, B. Braun Medical AG has designed COVID-19 vaccination sets for hospitals. The MedTech ...
Actualités 16 Mag 2023 NewBiologix, pionnier des thérapies géniques révolutionnaires, lève USD 50 millions NewBiologix, une start-up de biotechnologie fondée par les vétérans de l’industrie Igor Fisch et Nicolas Mermod, a annoncé une levée de fonds de ...
News 16 Mag 2023 NewBiologix pioneers breakthrough gene therapies with USD 50 million investment NewBiologix, a biotechnology start-up founded by industry veterans Igor Fisch and Nicolas Mermod, has announced a USD 50 million Series A funding...
Aktuell 06 Ott 2022 Forschende verbessern Medikament zur Diagnose von Tumoren Forschende des Paul Scherrer Instituts und der Eidgenössischen Technischen Hochschule Zürich konnten die Nebenwirkungen eines Medikaments zum Auf...
ニュース 28 Feb 2022 AIスキルの強化で組織力アップへ AI Master Class を提供中 AI、データ、自動化スキル、経営幹部スキルを発展させたい方は、ぜひAI Master Class オンラインプログラムをご活用ください。
News 14 Set 2018 Light controls medicinal patch One way of administering medication to a patient is through a skin patch. Researchers at Empa in St.Gallen together with colleagues at the Univer...
Novità 09 Giu 2022 Digitalizzazione e applicazioni AI in medicina all'Università di Berna Un gruppo di ricerca dell'Università di Berna e dell'Inselspital sta studiando e sviluppando approcci innovativi che consentiranno una diagnosi e...
News 06 Ott 2022 Researchers develop improved tumor diagnosis drug Researchers from the Paul Scherrer Institute and Swiss Federal Institute of Technology in Zurich have succeeded in their attempts to optimize the...
Aktuell 20 Gen 2021 B. Braun produziert COVID-19-Impfsets Die B. Braun Medical AG hat mit Bundesbehörden COVID-19-Impfsets für Spitäler konzipiert. Der Medtech-Hersteller hat die einzelnen Komponenten be...
News 24 Set 2021 Lonza builds new filling line in Stein Lonza is investing in the development and manufacture of medicinal products in Switzerland. The pharmaceutical supplier is constructing a new fil...
Aktuell 08 Ott 2019 leadXpro und Lundbeck forschen jetzt gemeinsam leadXpro und Lundbeck gehen eine strategische Partnerschaft ein. Gemeinsam wollen die beiden Biotech-Unternehmen Medikamente für Hirnerkrankungen...
News 13 Ott 2021 CHUV and EPFL discover a highly potent antibody against SARS-CoV-2 CHUV and EPFL have discovered a highly potent monoclonal antibody targeting the SARS-COV-2 Spike protein. This antibody neutralizes all variants ...
News 09 Feb 2022 ADC Therapeutics secures USD 30 million in new partnership deal ADC Therapeutics’ new partnership will focus on the development and commercialization of ZYNLONTA in Japan, for which the Vaud-based company will...
Success stories 05 Mar 2019 «Der Umzug nach Basel war in jeder Hinsicht perfekt.» Im Jahr 2015 entschied sich das globale IT-Unternehmen Aequor Technologies für Basel und gründete Aequor Consulting GmbH als lokale Basis für den...
News 12 Nov 2021 Bachem lays foundation stone for production building Bachem has laid the foundation stone for its largest production building to date. The company specializing in the manufacture of peptides and oli...
Actualités 13 Apr 2021 Lonza va créer 1’200 nouveaux emplois sur son site de production de vaccins Covid-19 à Viège Le géant de la biopharmaceutique Lonza a annoncé la création de 1’200 nouveaux emplois pour la fabrication du vaccin Covid-19 de Moderna sur son ...